Skip to main content
Main navigation
Home
About pCPA
Who We Are
Governance
FAQs
Negotiations
Recent Updates
Forms and Publications
Brand Name Drugs
Negotiations Status
Negotiation Process
Generic Drugs
Biologics/Biosimilars
Contact Us
EN
FR
Rebif (interferon beta-1a)
pCPA File Number:
20839
Negotiation Status:
Concluded with an LOI
Indication(s):
Clinically Isolated Syndrome
Sponsor/Manufacturer:
EMD Serono a Division of EMD Inc. Canada
CADTH Project Number:
SR0298
pCPA Engagement Letter Issued:
2013-10-11
Negotiation Process Concluded:
2015-04-21